Xenex Disinfection Services: Xenex LightStrike Disinfection Robots Now Available in UK Via Countess of Chester Commercial Procurement Services Framework
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210406005802/en/
Public sector organizations including hospitals, police forces, fire and rescue services, educational establishments, hospices, housing associations and other public entities in the UK can acquire LightStrike disinfection robots via the Countess of Chester CPS Framework. (Photo: Business Wire)
For the first time, public sector organizations including hospitals, police forces, fire and rescue services, educational establishments, hospices, housing associations and other public entities in the UK can easily acquire LightStrike disinfection robots via the Countess of Chester CPS Framework.
Investegate |Malin Corp PLC Announcements | Malin Corp PLC: Migration of Participating Securities investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Xenex Announces DEACTIVATE Handheld Disinfection Device; Proven to Destroy SARS-CoV-2 on Surfaces in 30 Seconds
February 10, 2021 GMT
The Deactivate handheld disinfection device is portable and adaptable for a variety of applications, allowing operators to quickly disinfect commonly touched areas between use. (Photo: Business Wire)
The Deactivate handheld disinfection device is portable and adaptable for a variety of applications, allowing operators to quickly disinfect commonly touched areas between use. (Photo: Business Wire)
SAN ANTONIO (BUSINESS WIRE) Feb 10, 2021
Xenex Disinfection Services Inc., a world leader in UV technology-based disinfection strategies and solutions, today announced the launch of Deactivate™, a high-powered, handheld LED device designed to quickly disinfect surfaces in confined spaces.
· Value of Malin s stake in Immunocore is approximately €51 million · Malin retains an approximate 6% stake in Immunocore following the IPO Dublin-Ireland, 5 February 2021 : Malin Corporation plc. (Euronext Growth Dublin:MLC) (Malin), a company investing in highly innovative life sciences companies, today notes that its investee company, Immunocore, has announced the pricing of its initial public offering (IPO) of 9.9 million American Depositary Shares (ADSs) representing 9.9 million ordinary shares at an initial public offering price of $26.00 per ADS for total gross proceeds of approximately $258 million. Immunocore also raised $15 million in a concurrent private placement. Immunocore s ADSs are expected to begin trading on The Nasdaq Global Select Market today (5 February 2021) under the ticker symbol IMCR . In addition, Immunocore has granted the underwriters a 30-day option to purchase up to an additional
Malin Corporation said that its investee company Immunocore has announced the pricing of its initial public offering (IPO) at a price of $26 per share which will result in total gross proceeds of about $258m.